Mariela Paoli-de ValeriYajaira Zerpa-de MilianiEzio G. Valeri-DávilaGabriela Arata de Bellabarba2026-03-222026-03-22199910.1590/s0036-36341999000200006https://doi.org/10.1590/s0036-36341999000200006https://andeanlibrary.org/handle/123456789/59655Citaciones: 2Treatment of asthmatic children with low doses of inhaled budesonide did not modify the adrenal axis function nor lipid metabolism. Asthmatic patients showed an atherogenic lipid profile which could increase the risk of cardiovascular disease.esBudesonideMedicineInternal medicineAsthmaEndocrinologyBasal (medicine)Urinary systemLipid profileCholesterolarticle